News | Treatment Planning | January 31, 2019

Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning

Agreement will streamline treatment planning software and imaging solutions to improve workflow

Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning

January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc. to improve radiation therapy treatment planning. With its integrated portfolio of computed tomography (CT) and magnetic resonance imaging (MRI) systems and intelligent treatment planning software, Philips supports clinicians in making confident therapy decisions. MIM Software provides practical imaging, automation and data analysis solutions to radiation therapy clinics worldwide.

By collaborating to integrate their radiation oncology solutions, Philips and MIM Software will enable clinicians to benefit from a more streamlined approach to treatment planning across the two companies’ portfolios.

Philips recently unveiled its new radiation oncology portfolio, including its new Big Bore RT and Ingenia Ambition/Elition MR-RT imaging systems and Pinnacle Evolution treatment planning software.

MIM Maestro, MIM Software’s flagship radiation oncology package, provides a comprehensive set of oncology solutions to automate the clinical workflow including image registration, auto-contouring and dose evaluation.

The agreement with MIM Software follows other recent partnerships in radiation oncology for Philips. In early 2018, Philips announced it is collaborating with Sun Nuclear to integrate its suite of PlanIQ software into its Pinnacle treatment planning platform. Later in the year at the American Society for Radiation Oncology’s (ASTRO) 60th Annual Meeting and Exhibition, Philips announced an agreement with Lifeline Software Inc. to utilize its fully automated independent dose verification technology.

For more information: www.usa.philips.com/healthcare, www.mimsoftware.com

Related Content

Sponsored Content | Videos | Artificial Intelligence | February 21, 2020
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intel
Sponsored Content | Videos | Enterprise Imaging | February 21, 2020
In Enterprise Imaging at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overvie
Chest CT imaging of patient. #coronavirus #nCoV2019 #2019nCoV #COVID19

Examples of typical chest CT findings compatible with COVID-19 pneumonia in patients with epidemiological and clinical presentation suspicious for COVID-19 infection. This image is part of the original research, Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR, published Feb. 19, 2020, in Radiology Online.

News | Computed Tomography (CT) | February 19, 2020
February 19, 2020 — In new research
Sponsored Content | Videos | Enterprise Imaging | February 19, 2020
Bill Lacy, vice president, Medical Informatics at FUJIFILM Medic...
Sponsored Content | Videos | Flat Panel Displays | February 19, 2020
EIZO medical monitors were showcased recently at RSN...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Nuclear imaging equipment growth in 2020
News | Nuclear Imaging | February 14, 2020
February 14, 2020 — The nuclear imaging equipment